Central to the designed total synthesis of the apratoxins
is the formation of the 2,4-disubstituted thiazoline moiety.
Several methods have been developed for the construction
of this type of structural motif.4 These include the direct
thermal intramolecular cyclization of thiolesters derived from
vicinal amino thiols,5 TiCl4-induced dehydration of amides
derived from vicinal amino thiols,6 condensation of nitriles
with 2-aminothiols,7 addition of aminothiols to imidate
esters,8 combination of a thiolamide with ethyl bromopyru-
vate,8 sulfurization of oxazolines,9 cyclization of a serine-
derived thiolamide with10 or without11 the use of Burgess’
reagent, phosphine-induced annulation of thiolamides and
2-alkynoates,12 and an intramolecular aza-Wittig reaction of
a thiolester.13 Due to its simplicity and directness, the
application of Fukuyama’s acid-induced cyclization of an
R-amino thiolester5 was explored first for the synthesis of
apratoxins’ thiazoline.
This provided two major diastereomeric products 7, both
of which contained the anticipated thiazoline unit. However,
both diastereomers unexpectedly also had incorporated a
tetrahydropyran.
This likely results from acid-induced â-elimination to form
a trisubstituted alkene and hetero-Michael addition of the
residual hydroxyl moiety resulting from TES ether cleavage.
The â-elimination process is clearly related to the reported
acid-catalyzed dehydration of apratoxin A to form (E)-34,35-
dehydroapratoxin A in CDCl3.2 To prevent unwanted dehy-
dration, several thiol esters with different amino and hydroxyl
protecting groups were investigated under the Fukuyama
acid-induced cyclization conditions. But none of those
examined were fruitful. Hence, a key synthetic challenge en
route to the total synthesis of the apratoxins was under-
scored: installation and maintenance of the 2-(â-hydroxy)-
thiazoline.
Thiol ester 6, in which the amine was engaged in a tert-
butyl carbamate, was prepared from carboxylic acid 4 and
the thiol 5 (Scheme 1).14 Compound 4 represents the
Thus, an alternative process for mild thiazoline formation
that would avoid the observed propensity of dehydration/
elimination to give a 2-alkenyl-substituted thiazoline was
sought. This requirement, in conjunction with the basic
synthetic strategy toward the apratoxins, led to the identifica-
tion of a uniquely mild process for de novo thiazoline
formation. The neutral reaction conditions involved in
phosphinimine generation from an azide via Staudinger
reduction and the opportunity for subsequent intramolecular
aza-Wittig reaction under the same anhydrous reaction
conditions15 prompted the exploration of vicinal azido
thiolesters for mild thiazoline formation in the apratoxin
system (Scheme 2). This concept was found to have
Scheme 1. Dehydrative Thiazoline/Tetrahydropyran Formation
Scheme 2. Staudinger Reduction/Intramolecular Aza-Wittig
Process for Nondehydrative Thiazoline Formation
polyketide domain of apratoxins A and B, and 5 is an N-
and C-blocked version of the modified cysteine moiety of
the apratoxins. Following the Fukuyama protocol,5 exposure
of 6 to TFA in CH2Cl2 to cleave the carbamate moiety
followed by removal of solvent and excess TFA gave a
residue that was heated at reflux in benzene.
precedence in the generation of pyranoside-fused thiazolines
as protected forms of vicinal amino-thiols.13
The S-AW process has also been applied to the synthesis
of cyclic imines and an oxazoline.16 However, the acid
sensitivity of the apratoxins’ 2-(â-hydroxy)-thiazoline moiety
presented an unprecedented challenge for convergent thia-
zoline synthesis under mild, nondehydrative conditions.
Several thiolester-azides related to the modified cysteine
moiety of the apratoxins were prepared (Scheme 3). Selective
(4) (a) Wipf, P.; Venkatraman, S. Synlett 1997, 1. (b) Kedrowski, B.;
Heathcock, C. H. Heterocycles 2002, 58, 601.
(5) Fukuyama, T.; Xu, L. J. Am. Chem. Soc. 1993, 115, 8449.
(6) Walker, M. A.; Heathcock, C. H. J. Org. Chem. 1992, 57, 5566.
(7) Ehrler, J.; Farooq, S. Synlett 1994, 702.
(8) (a) Inamli, K.; Shiba, T. Bull. Chem. Soc. Jpn. 1986, 115, 8449. (b)
Pattenden, G.; Thom, S. M. J. Chem. Soc., Perkin Trans. 1 1993, 1629.
(9) Wipf, P.; Miller, C. P. Tetrahedron Lett. 1992, 33, 6267.
(10) Wipf, P.; Fritch, P. C. Tetrahedron Lett. 1994, 35, 5397.
(11) Zarantonello, P.; Leslie, C. P.; Ferritto, R.; Kazmierski, W. M.
Bioorg. Med. Chem. Lett. 2002, 12, 561.
(15) For reviews on the Staudinger/aza-Wittig process, see: (a) Molina,
P.; Vilaplana, M. J. Synthesis 1994, 1197. (b) Eguchi, E.; Matsushita, Y.;
Yamashita, K. Org. Prep. Proced. 1992, 24, 209.
(16) Mulzer, J.; Meier, A.; Buschmann, J.; Luger, P. Synthesis 1996,
123.
(12) Liu, B.; Davis, R.; Joshi, B.; Reynolds, D. W. J. Org. Chem. 2002,
67, 4595 and references therein.
(13) Brossmer, R.; Mack, H. Tetrahedron Lett. 1981, 22, 933.
(14) Details of the preparation of 4-12d will be reported in due course.
1282
Org. Lett., Vol. 5, No. 8, 2003